Sartorius Raises Guidance Following Strong First Half
Sartorius successfully closed the first six months of 2012, with substantial gains in order intake, sales revenue and earnings. The Bioprocess Solutions Division that primarily specializes in single-use products for pharmaceutical drug manufacture performed especially well. Furthermore, initial consolidation of the Biohit Liquid Handling business considerably boosted growth for the Laboratory Products & Services Division.
Based on the company's strong first-half results, management lifted its guidance for the full year of 2012. Accordingly, Sartorius now expects its sales to grow by about 11% in constant currencies (former guidance: +10%). In addition, provided that currency exchange rates remain favorable as in the first half, adjusted earnings (operating EBITA) are projected to increase by around 15% (former guidance: +10%).
Read more at